About Javelin Pharmaceuticals
Javelin Pharmaceuticals is a company based in Cambridge (United States) founded in 1998 was acquired by Hospira in April 2010.. Javelin Pharmaceuticals operates in a competitive market with competitors including Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and Egalet, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Javelin Pharmaceuticals, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Javelin Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $750,000
-
First Round
First Round
(03 Nov 2005)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2006 | Amount | Grant - Javelin Pharmaceuticals | Valuation |
investors |
|
| Nov, 2005 | Amount | Debt – Conventional - Javelin Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Javelin Pharmaceuticals
Javelin Pharmaceuticals has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Hospira and National Cancer Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NGN Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
Wexford Capital is engaged in alternative investment solutions.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Javelin Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Javelin Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Javelin Pharmaceuticals Comparisons
Competitors of Javelin Pharmaceuticals
Javelin Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and Egalet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for pain management are developed with abuse-deterrent designs.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Javelin Pharmaceuticals
Frequently Asked Questions about Javelin Pharmaceuticals
When was Javelin Pharmaceuticals founded?
Javelin Pharmaceuticals was founded in 1998 and raised its 1st funding round 7 years after it was founded.
Where is Javelin Pharmaceuticals located?
Javelin Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Javelin Pharmaceuticals?
Martin Driscoll is the current CEO of Javelin Pharmaceuticals.
What does Javelin Pharmaceuticals do?
Javelin Pharmaceuticals, a speciality pharmaceutical company, engages in the development of novel drugs and improved formulations of existing drugs for various pain disorders including cancer pain, post-operative pain, post-trauma pain, procedural pain, and burn pain. The companys Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the UK and was licensed to Therabel Pharma for commercialization in the Europe. Its drug pipeline Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for the treatment of acute moderate-to-severe pain. The company was acquired by Hospira (a subsidiary of Pfizer) in Apr 2010.
Who are the top competitors of Javelin Pharmaceuticals?
Javelin Pharmaceuticals's top competitors include Flexion Therapeutics, Cara Therapeutics and Satsuma Pharmaceuticals.
Who are Javelin Pharmaceuticals's investors?
Javelin Pharmaceuticals has 7 investors. Key investors include NIH, Hospira, National Cancer Institute, Therabel, and Myrexis.